BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 22700957)

  • 1. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.
    Qiu X; Audet J; Wong G; Pillet S; Bello A; Cabral T; Strong JE; Plummer F; Corbett CR; Alimonti JB; Kobinger GP
    Sci Transl Med; 2012 Jun; 4(138):138ra81. PubMed ID: 22700957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms.
    Qiu X; Wong G; Fernando L; Audet J; Bello A; Strong J; Alimonti JB; Kobinger GP
    Sci Transl Med; 2013 Oct; 5(207):207ra143. PubMed ID: 24132638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb.
    Qiu X; Audet J; Wong G; Fernando L; Bello A; Pillet S; Alimonti JB; Kobinger GP
    Sci Rep; 2013 Nov; 3():3365. PubMed ID: 24284388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
    Geisbert TW; Hensley LE; Geisbert JB; Jahrling PB
    Virology; 2002 Feb; 293(1):15-9. PubMed ID: 11853394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus.
    Qiu X; Audet J; Lv M; He S; Wong G; Wei H; Luo L; Fernando L; Kroeker A; Fausther Bovendo H; Bello A; Li F; Ye P; Jacobs M; Ippolito G; Saphire EO; Bi S; Shen B; Gao GF; Zeitlin L; Feng J; Zhang B; Kobinger GP
    Sci Transl Med; 2016 Mar; 8(329):329ra33. PubMed ID: 26962157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation in nonhuman primates of vaccines against Ebola virus.
    Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
    Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection.
    Shcheblyakov D; Esmagambetov I; Simakin P; Kostina L; Kozlov A; Tsibezov V; Grebennikova T; Chifanov D; Rumyantseva I; Boyarskaya N; Sizikova T; Shagarova N; Andrus А; Shatohina I; Syromyatnikova S; Kovalchuk A; Pantyukhov V; Borisevich S; Zubkova O; Tukhvatulin A; Logunov D; Naroditsky B; Gintsburg A
    Antiviral Res; 2019 Dec; 172():104617. PubMed ID: 31593751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.
    Marzi A; Feldmann F; Hanley PW; Scott DP; Günther S; Feldmann H
    Emerg Infect Dis; 2015 Oct; 21(10):1777-83. PubMed ID: 26402165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
    Wong G; Richardson JS; Pillet S; Racine T; Patel A; Soule G; Ennis J; Turner J; Qiu X; Kobinger GP
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S379-83. PubMed ID: 25957963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
    Warfield KL; Swenson DL; Olinger GG; Nichols DK; Pratt WD; Blouch R; Stein DA; Aman MJ; Iversen PL; Bavari S
    PLoS Pathog; 2006 Jan; 2(1):e1. PubMed ID: 16415982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of neutralizing antibodies against Ebola virus infection.
    Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
    Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a preventive vaccine for Ebola virus infection in primates.
    Sullivan NJ; Sanchez A; Rollin PE; Yang ZY; Nabel GJ
    Nature; 2000 Nov; 408(6812):605-9. PubMed ID: 11117750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.
    Pettitt J; Zeitlin L; Kim DH; Working C; Johnson JC; Bohorov O; Bratcher B; Hiatt E; Hume SD; Johnson AK; Morton J; Pauly MH; Whaley KJ; Ingram MF; Zovanyi A; Heinrich M; Piper A; Zelko J; Olinger GG
    Sci Transl Med; 2013 Aug; 5(199):199ra113. PubMed ID: 23966302
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Woolsey C; Borisevich V; Agans KN; Fenton KA; Cross RW; Geisbert TW
    mBio; 2021 Aug; 12(4):e0151721. PubMed ID: 34372693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
    Jahrling PB; Geisbert JB; Swearengen JR; Larsen T; Geisbert TW
    J Infect Dis; 2007 Nov; 196 Suppl 2():S400-3. PubMed ID: 17940976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.
    Alfson KJ; Avena LE; Beadles MW; Staples H; Nunneley JW; Ticer A; Dick EJ; Owston MA; Reed C; Patterson JL; Carrion R; Griffiths A
    J Virol; 2015 Jul; 89(13):6773-81. PubMed ID: 25903348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.